The Ministry of Health (Kemenkes) recorded four districts/cities in Jambi with a weekly average vaccination rate above the provincial average of 893.25 doses as of Monday, June 20, 2022.
The three top districts/cities with average vaccination rates exceeding 1,000 doses are Tebo, Kerinci, and Tanjung Jabung Barat, with 1,218 doses, 1,096 doses, and 1,074 doses respectively.
Tebo ranks first with a weekly average vaccination rate of 1,218 doses. Vaccine usage up to yesterday was recorded at 382,040 doses. Based on the national dashboard recapitulation, the complete vaccination rate in this region has reached 82.69 percent.
According to the Ministry of Health, the available vaccine stock in this district will run out within the next 15 days. This remaining usage time is calculated based on the available stock of 18,486 doses and the highest weekly vaccine usage in Jambi.
Next is Kerinci, which recorded a weekly average vaccination rate of 1,096 doses, lower than the previous week. Kerinci ranks second. With this average vaccine usage, the vaccine stock in this region will last for 12 days. The remaining vaccine stock is currently 14,096 doses.
Next is Tanjung Jabung Barat with a weekly average vaccination rate of 1,074 doses. The complete vaccination coverage has reached 80.92 percent. Merangin has a vaccination rate of 953 doses and a complete vaccination coverage of 63.66%, and Bungo has a weekly average vaccination rate of 806 doses and a complete vaccination coverage of 71.12%.
Some of the regions outside Java with the highest average vaccination rates include Simalungun, Rokan Hulu, and Lampung Tengah, with average vaccination rates of 7,506 doses, 6,305 doses, and 6,083 doses respectively.
Although COVID-19 transmission has decreased in some areas, the government urges everyone to help reduce COVID-19 transmission by consistently wearing masks, maintaining physical distance, and frequently washing hands with soap and running water. Avoiding crowds and reducing mobility also contribute to suppressing the spread of the coronavirus.